新华时评：惩治“阴阳价”！定点药店岂能“看人下菜碟”

Core Points - The article highlights the issue of "yin-yang pricing" in pharmacies, where the price of the same cold medicine varies significantly between insured and uninsured customers, with insured customers paying 31 yuan compared to 17 yuan for uninsured customers, indicating a nearly 100% price difference [1] - The practice of "yin-yang pricing" undermines the safety of the medical insurance fund and damages the interests of insured individuals, leading to a loss of public trust in the medical insurance system [1] - Recent regulations have been introduced to strengthen monitoring and handling of "yin-yang pricing" in designated retail pharmacies, emphasizing the need for strict investigation and punishment [1] Group 1 - The article discusses the reasons behind the prevalence of "yin-yang pricing," including the financial pressures on some pharmacies and the lack of transparency in drug pricing, which allows for exploitation of insured patients [1] - It emphasizes that the medical insurance fund is crucial for the public, and any misappropriation of funds is unacceptable [1] - The article calls for a collaborative effort among medical insurance, market regulation, and drug supervision departments to effectively combat "yin-yang pricing" [1] Group 2 - The article suggests that technological solutions, such as drug price comparison apps and comprehensive use of drug traceability codes, should be implemented to create a multi-dimensional supervision network [2] - It advocates for the public display of reporting channels in pharmacies to enhance community oversight [2] - The article concludes that the qualification for medical insurance designated pharmacies should be viewed as a responsibility for honest operation, and that punishing "yin-yang pricing" will lead to fairer and more transparent drug purchasing for the public [2]